Stay updated on Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The site footer’s revision identifier changed from v3.7.2 to v3.8.0. The study record continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:57:34.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    An NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the error page, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T23:58:03.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:15:21.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content with an access-denied message. The navigation and links that previously allowed viewing the trial details are no longer accessible on this page.
    Difference
    18%
    Check dated 2026-09-23T01:05:02.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.6 to v3.7.0, signaling an underlying software update to the page. This change does not modify the study details, eligibility criteria, or results presented on the page.
    Difference
    0.0%
    Check dated 2026-09-16T00:16:38.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Revision label updated from Revision: v3.6.5 to Revision: v3.6.6, reflecting a newer underlying build. This change does not modify the study content or visible functionality.
    Difference
    0.0%
    Check dated 2026-09-01T19:44:30.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page.